首页|ω-3多不饱和脂肪酸对大鼠慢性萎缩性胃炎的保护作用研究

ω-3多不饱和脂肪酸对大鼠慢性萎缩性胃炎的保护作用研究

扫码查看
目的 探讨ω-3多不饱和脂肪酸(ω-3 PUFA)对大鼠慢性萎缩性胃炎的影响.方法 用综合法建立慢性萎缩性胃炎大鼠模型.将造模成功的大鼠随机分为低、中、高剂量实验组、模型组、阳性对照组.另取正常大鼠作为正常组,每组9只.低、中、高剂量实验组每日分别灌胃3、6、12 mL·kg-1 ω-3 PUFA.阳性对照组每日灌胃0.24 g·kg-1的维酶素混悬液.正常组和模型组每日灌胃等量0.9%NaCl.持续给药12周.用酶联免疫吸附试验(ELISA)法检测血清白细胞介素-1β(IL-1β)水平,用原位末端标记(TUNEL)染色法检测胃黏膜组织细胞凋亡情况,用试剂盒检测超氧化物歧化酶(SOD)、丙二醛(MDA)水平.结果 正常组、模型组、低剂量实验组、中剂量实验组、高剂量实验组、阳性对照组的 IL-1β 水平分别为(58.96±8.23)、(140.02±19.65)、(109.81±14.35)、(98.72±12.64)、(85.31±11.42)和(77.64±10.23)pg·mL-1,凋亡指数分别为(7.89±1.36)%、(77.12±10.05)%、(42.33±6.87)%、(31.05±5.29)%、(22.76±4.16)%和(16.89±3.05),SOD 水平分别为(398.71±58.24)、(170.25±29.81)、(249.81±34.26)、(268.04±34.11)、(322.15±46.36)和(276.42±29.81)U·mg-1,MDA 水平分别为(3.55±0.87)、(11.02±2.15)、(8.02±1.50)、(6.92±1.23)、(5.98±1.27)和(6.67±1.32)U·mg-1.模型组的上述指标与正常组比较,在统计学上差异均有统计学意义(均P<0.01);低、中、高剂量实验组、阳性对照组的上述指标与模型组比较,在统计学上差异均有统计学意义(均P<0.01).结论 ω-3 PUFA可改善大鼠慢性萎缩性胃炎,其机制可能与ω-3 PUFA的抗炎、抗凋亡和抗氧化应激作用有关.
Protective effects of omega-3 polyunsaturated fatty acids on chronic atrophic gastritis of rats
Objective To investigate the effect of omega-3 polyunsaturated fatty acids(ω-3 PUFA)on chronic atrophic gastritis of rats.Methods A rat model of chronic atrophic gastritis was established by synthetic method.The rats successfully modeled were randomly divided into model group,experimental-L group,experimental-M group,experimental-H group,positive control group.Normal rats were selected as the normal group.There were 9 rats in each group.Experimental-L,-M,-H groups were given 3,6 and 12 mL·kg-1ω-3 PUFA daily,respectively.The positive control group was given 0.24 g·kg-1 vitacoenzyme suspension daily.Normal group and model group were given the same amount of 0.9%NaCl.Each group was given the drug for 12 weeks.Enzyme-linked immunosorbent assay(ELISA)was used to detect serum interleukin-1 β(IL-1β)level.In situ end labeling staining(TUNEL)was used to detecte the apoptosis of gastric mucosa.Relevant kits were used to detect the level of superoxide dismutase(SOD)and malonaldehyde(MDA).Results IL-1 β levels in normal group,model group,experimental-L,-M,-H groups and positive control group were(58.96±8.23),(140.02±19.65),(109.81±14.35),(98.72±12.64),(85.31±11.42)and(77.64±10.23)pg·mL-1,respectively;apoptotic indices were(7.89±1.36)%,(77.12±10.05)%,(42.33±6.87)%,(31.05±5.29)%,(22.76±4.16)%and(16.89±3.05)%,respectively;SOD levels were(398.71±58.24),(170.25±29.81),(249.81±34.26),(268.04±34.11),(322.15±46.36)and(276.42±29.81)U·mg-1,respectively;MDA levels were(3.55±0.87),(11.02±2.15),(8.02±1.50),(6.92±1.23),(5.98±1.27)and(6.67±1.32)U·mg-1,respectively.Compared with normal group,the above indexes were significantly different in model group(all P<0.01);compared with model group,the above indexes were significantly different in experimental-L,experimental-M,experimental-H groups and positive control group(all P<0.01).Conclusionω-3 PUFA can ameliorate chronic atrophic gastritis of rats,and the mechanism may be related to the anti-inflammatory,anti-apoptosis and anti-oxidative stress effects of to-3 PUFA.

omega-3 polyunsaturated fatty acidchronic atrophic gastritisinflammationapoptosisoxidative stress

彭敦煌、尤德源、洪才发、房太勇

展开 >

福建医科大学附属第二医院消化内科,福建泉州 362000

ω-3多不饱和脂肪酸 慢性萎缩性胃炎 炎症 凋亡 氧化应激

福建省自然科学基金

2020J01242

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(2)
  • 10